Of Monsters and Men
By George Estreich, Biopolitical Times guest contributor
| 11. 29. 2012
To be interested in questions of human enhancement, while also being a sucker for Hollywood blockbusters about superheroes, makes for an odd movie experience. Immersed in a fictional world both saved and threatened by the enhanced, you’re aware of the world you’ve just paid to escape. You feel doubled, like the superheroes themselves—though since you’re sitting on the couch and not saving the world, the division is less profound. You don’t have secret powers, just cognitive dissonance; your perception, not your identity, is split.
A few nights ago, I watched The Amazing Spider-Man on Blu-Ray. (Warning: many spoilers ensue.) The movie reboots the franchise that began in 2002, and this time around, the genetic enhancement of human beings is far more central to the plot. Just as in the first series, the high school student Peter Parker, bitten by a genetically modified spider, develops superpowers; but this time around, the spider comes from a corporation whose business model depends on “cross-species genetics,” and Peter’s nemesis—the scientist Curtis Connors, once the research partner of Peter’s deceased father—is a man with one...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...